Trials / Sponsors / Daiichi Pharmaceuticals
Daiichi Pharmaceuticals
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer Lung Cancer | Phase 2 | 1999-02-01 |
| Completed | A Study of Tecogalan Sodium Sarcoma, Kaposi, HIV Infections | Phase 1 | — |
| Completed | A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days. Sarcoma, Kaposi, HIV Infections | Phase 1 | — |
| Completed | A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days Sarcoma, Kaposi, HIV Infections | Phase 1 | — |
| Withdrawn | Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | — |
| Completed | A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4 Sarcoma, Kaposi, HIV Infections | Phase 1 | — |